SAN DIEGO, February 23, 2012 — TearLab Corporation (Nasdaq:TEAR: TSX:TLB) (“TearLab” or the “Company”) announced today that it has entered into a consulting agreement with one of its directors, Dr. Adrienne Graves, pursuant to which Dr. Graves will oversee identifying and leading discussions with potential partners for the commercialization of the TearLab Osmolarity System in Japan.

Dr. Graves has been a member of TearLab’s Board since April 2005 and, from 2002 to 2010 was President and Chief Executive Officer of Santen Inc., the U.S. subsidiary of Japan’s Santen Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4536). She joined Santen Inc. in 1995 as Vice President of Clinical Affairs to initiate its clinical development in the U.S. Under her leadership, Santen’s research and development team successfully developed and obtained U.S. Food and Drug Administration approval for three ophthalmic products in major therapeutic areas. Prior to joining Santen Inc., Dr. Graves spent nine years with Alcon Laboratories, Inc. (“Alcon”) beginning in 1986 as a Senior Scientist. She was named Associate Director of Alcon’s Clinical Science Division in 1992 and then Alcon’s Director of International Ophthalmology in 1993.

Dr. Graves is the author of over 30 research papers. She is a member of a number of professional associations, including the Association for Research in Vision and Ophthalmology, the American Academy of Ophthalmology, the American Glaucoma Society, and Women in Ophthalmology. She also serves on the Boards of the American Academy of Ophthalmology Foundation, the Pan-American Association of Ophthalmology, the American Association for Cataract and Refractive Surgery, the Glaucoma Research Foundation and the Corporation Committee for the Brown University Medical School. In addition, Dr. Graves co-founded Ophthalmic Women Leaders with Dr. Marguerite McDonald.

“Like in the U.S. and Europe, the Dry Eye Disease patient population in Japan is large and growing,” commented Elias Vamvakas, TearLab’s Chief Executive Officer.   “Adrienne’s extraordinary international executive experience, broad network of industry contacts and special knowledge of the Japanese ophthalmic corporate culture make her the ideal person to help us explore commercial partnership opportunities for the TearLab Osmolarity System in this important market.”

About Dry Eye Disease (DED) in Japan

DED is a common condition in which the eye does not produce enough tears to keep the surface of the eye sufficiently lubricated. It affects approximately 22 million people in Japan and 100 million people worldwide.  Recent studies have found the incidence of DED in high schools in Japan to be about 5%(1), and among office workers using visual display terminals, the incidences reported were 10% of men and 20% of women(2).

References

1. Uchino M, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Takebayashi T, et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol. 2008;146(6): 925-929.e2.

2. Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology. 2008;115(11):1982-1988.

The Secondary Plan(SP) amendment for the Nigus parcel(south) continues to progress favorably and on schedule. The SP will be comprised of a comprehensive number  maps and schedules, as well as various studies and background reports which will govern how the area is to be developed: where the low-density (homes), schools and parks will be located and divided throughout the property; how the site will be serviced by infrastructure (sewers, water and roads); and how the environment will be protected and enhanced throughout the development process.  The aforementioned reports will be submitted,  individually upon their completion, for review and approval to the respective Agencies within the Municipality.

As part of a massive expansion initiative throughout Canada, the American discount retailer – Target is taking over the Zellers store, currently located on 900 Tower Street S., in the Fergus Mall. The store is scheduled to close on September 15 2012, and will undergo massive renovations – set to be complete in the spring of 2013. The proximity of the store’s location to the development site is illustrated below:

Elias Vamvakas, TearLab’s Chief Executive Officer, commented, “We believe that, with CLIA Waiver and Medicare reimbursement in place, and with the updated American Academy of Ophthalmology’s Preferred Practice Pattern guidelines listing tear osmolarity as a more sensitive method to diagnose Dry Eye Disease, the TearLab Osmolarity test is now well on its way toward being established as a standard of care.”

Market reaction:

“This marks the achievement of our third and final major milestone,” commented Elias Vamvakas, TearLab’s Chief Executive Officer.

Mr. Vamvakas continued, “We believe that in order for the TearLab Osmolarity System to become widely adopted, it is essential that it be accessible at the point-of-care. Now, with the CLIA waiver obstacle overcome, this groundbreaking test is free to start growing to its potential.”

Photography: Greybrook Realty Partners

November 30, 2011

WILLIAM CONWAY/PROGRESS PHOTOGRAPHY

Construction progresses for the King West condominium project in Toronto.

Construction manager TMG Builders along with Plazacorp Properties Ltd. began the three- tower project with four levels of underground parking in winter 2010 and completion is scheduled for mid 2012. The project includes one 25-storey tower, two 23-storey towers with a total of 1177 units and townhomes in a three-level podium.

The project was designed by Quadrangle Architects Ltd./Gabriel Bodor Architect Inc. Structural consultant is Jablonsky Ast & Partners and mechanical/electrical consultant is Concord Consultants Ltd. Subtrades include: Anpro Environmental Group Inc. (excavation); Deep Foundations Contractors Inc.(shoring/caissons); Canada Wide Reinforcing Steel Co. Ltd.; Premform Ltd.; Global Precast Inc.; CBM (concrete); Venice Masonry; Primo Mechanical Inc.; Nortown Electrical Contractors Associates; York Sheet Metal (HVAC); State Window Corp. and ThyssenKrupp Elevator Ltd.

King West in progress

WILLIAM CONWAY/PROGRESS PHOTOGRAPHY

See October 5, 2011 story

WILLIAM CONWAY/PROGRESS PHOTOGRAPHY

See June 13, 2011 story

WILLIAM CONWAY/PROGRESS PHOTOGRAPHY

See March 28, 2011 story

The windows are currently being made off-site and the installation has extended to the 11th floor of the east tower.

The following pictures have been taken on Dec 12th.

Photography: Greybrook Realty Partners